z-logo
open-access-imgOpen Access
Lowering extracellular calcium content protects cells from arsenite-induced killing and micronuclei formation
Author(s) -
Yee-Chien Liu,
Haimei Huang
Publication year - 1996
Publication title -
mutagenesis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.723
H-Index - 91
eISSN - 1464-3804
pISSN - 0267-8357
DOI - 10.1093/mutage/11.1.75
Subject(s) - calcium , extracellular , verapamil , egta , arsenite , chemistry , calcium in biology , cytotoxicity , intracellular , calcium metabolism , calcium channel blocker , nitrendipine , micronucleus test , biochemistry , pharmacology , biology , toxicity , in vitro , arsenic , organic chemistry
The present study demonstrated that calcium ions were accumulated in nuclei of Chinese hamster ovary (CHO)-K1 cells after arsenite treatment. This process was enhanced by verapamil (a calcium channel blocker). Verapamil also significantly increased the cytotoxic effects of arsenite. In contrast, ethylene glycol-bis[beta-aminoethylether] N,N, N1,N1,-tetraacetic acid (EGTA, a calcium-specific chelator), or calcium-free conditions significantly reduced the cytotoxicity or arsenite. Similarly, the strategy of lowering extracellular calcium concentration by modifying the medium or lowering intracellular calcium concentration by administration of the intracellular calcium chelator quin 2, protected cells from arsenite-induced micronuclei formation. These data indicate that the disturbances in intracellular calcium homeostasis maybe involved in arsenite-induced cytotoxicity and micronuclei formation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom